Skip to search formSkip to main contentSkip to account menu

artemether 20 MG / lumefantrine 120 MG Oral Tablet [Coartem]

Known as: Coartem (artemether 20 MG / lumefantrine 120 MG) Oral Tablet, Coartem 20 MG / 120 MG Oral Tablet 
National Institutes of Health

Related topics

Related topics

13 relations
CoartemCroscarmellose SodiumMagnesium stearateOral Tablet

Broader (3)

Coartem Oral Productartemether / lumefantrine Oral Tablet [Coartem]artemether 20 MG / lumefantrine 120 MG Oral Tablet

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Performance of Interferon-Gamma and IP-10 Release Assays for Diagnosing Latent Tuberculosis Infections in Patients with Concurrent Malaria in Tanzania.
Interferon-gamma (IFN-γ) release assays (IGRAs) are used to detect cellular immune recognition of Mycobacterium tuberculosis The… 
2014
2014
Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling
BackgroundSuccessful programmatic use of anti-malarials faces challenges that are not covered by standard drug development… 
Review
2013
Review
2013
Treatment of fevers prior to introducing rapid diagnostic tests for malaria in registered drug shops in Uganda
BackgroundSince drug shops play an important role in treatment of fever, introducing rapid diagnostic tests (RDTs) for malaria at… 
2013
2013
Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem®) for bioequivalence in a randomized, open-label, two-period study
BackgroundArtemether-lumefantrine (Coartem®; AL) is a standard of care for malaria treatment as an oral six-dose regimen, given… 
Review
2013
Review
2013
Prescription patterns and drug use among pregnant women with febrile Illnesses in Uganda: a survey in out-patient clinics
BackgroundMalaria is a public health problem in Uganda; affecting mainly women and children. Effective treatment has been… 
2013
2013
Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem®) for bioequivalence in a randomized, open-label, two-period study
Artemether-lumefantrine (Coartem®; AL) is a standard of care for malaria treatment as an oral six-dose regimen, given twice daily… 
2012
2012
Assessment of Therapeutic Efficacy of Coartem® in Patients with Uncomplicated Plasmodium Falciparum Malaria in Halaba Special Woreda, Southern Ethiopia
2011
2011
Exploring provider and community responses to the new malaria diagnostic and treatment regime in Solomon Islands
BackgroundImprovements in availability and accessibility of artemisinin-based combination therapy (ACT) for malaria treatment and… 
Review
2009
Review
2009
Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia
Malaria is one of the most significant causes of morbidity and mortality worldwide. Every year, nearly one million deaths result… 
2009
2009
Mediziner und die CIA-Gefängnisse - Protonenpumppenhemmer - Novartis, Coartem® - diabetischen Retinopahtie - Koronare Bypasschirurgie - Drogenpolitik - Assoziation?
Noch «so was»: Koronare Bypasschirurgie (CABG) mit oder ohne ventrikuläre Rekonstruktion (VR)? VR ist ein Procedere, in welchem… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)